Mark Bresnik
Impact in
- Infectious Diseases top 2%
- Antifungal resistance and susceptibility
- Epidemiology top 5%
- Fungal Infections and Studies
- Nail Diseases and Treatments
- Pneumocystis jirovecii pneumonia detection and treatment
Papers in
-
- Cystic Fibrosis Research Advances 13
- Inhalation and Respiratory Drug Delivery 7
-
- Antifungal resistance and susceptibility 11
- Co-authors
- Ramin Ebrahimi (4 shared papers)Oliver A. Cornely (4 shared papers)Johan Maertens (4 shared papers)Raoul Herbrecht (4 shared papers)Andrew J. Ullmann (2 shared papers)Markus Ruhnke (1 shared paper)Anne Thiébaut (1 shared paper)Emilio Bouza (1 shared paper)
- Journals
- Journal of Cystic Fibrosis (12 papers)Journal of Antimicrobial Chemotherapy (2 papers)Mycoses (2 papers)Clinical Microbiology and Infection (2 papers)Antimicrobial Agents and Chemotherapy (2 papers)
- Partner nations
- United StatesUnited KingdomFrance
In The Last Decade
Mark Bresnik
22 papers receiving 927 citations
Mark Bresnik's Hit Papers
Peers
Comparison fields: 5 of 63
- Infectious Diseases 617
- Epidemiology 517
- Small Animals 89
- Pulmonary and Respiratory Medicine 298
- Molecular Medicine 31
Countries citing papers authored by Mark Bresnik
This map shows the geographic impact of Mark Bresnik's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Mark Bresnik with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Mark Bresnik more than expected).
Fields of papers citing papers by Mark Bresnik
This network shows the impact of papers produced by Mark Bresnik. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Mark Bresnik. The network helps show where Mark Bresnik may publish in the future.
Co-authors
The 25 scholars most cited alongside Mark Bresnik, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 28 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | Liposomal Amphotericin B as Initial Therapy for Invasive Mold Infection: A Randomized Trial Comparing a High-Loading Dose Regimen with Standard Dosing (AmBiLoad Trial) Hit paper breakdown → | 2007 | 555 |
| 2 | 2012 | 113 | |
| 3 | 2010 | 47 | |
| 4 | 2014 | 47 | |
| 5 | 2016 | 42 | |
| 6 | 2013 | 41 | |
| 7 | 2005 | 28 | |
| 8 | 2007 | 23 | |
| 9 | 2009 | 15 | |
| 10 | 2009 | 15 | |
| 11 | 2012 | 13 | |
| 12 | 2020 | 10 | |
| 13 | 2011 | 9 | |
| 14 | 2012 | 8 | |
| 15 | 2011 | 5 | |
| 16 | 2025 | 3 | |
| 17 | 2011 | 3 | |
| 18 | 2023 | 2 | |
| 19 | 2016 | 2 | |
| 20 | 2011 | 2 |
About Mark Bresnik
Mark Bresnik is a scholar working on Pulmonary and Respiratory Medicine, Infectious Diseases, Epidemiology, Pediatrics, Perinatology and Child Health and Small Animals, having authored 28 papers that have together received 986 indexed citations. Recurring topics across this work include Cystic Fibrosis Research Advances (13 papers), Antifungal resistance and susceptibility (11 papers), Fungal Infections and Studies (9 papers), Inhalation and Respiratory Drug Delivery (7 papers), Pharmaceutical studies and practices (4 papers), Infectious Diseases and Mycology (2 papers), Actinomycetales infections and treatment (1 paper) and Nail Diseases and Treatments (1 paper). The work is most often cited by research in Infectious Diseases (617 citations), Epidemiology (517 citations), Small Animals (89 citations), Pulmonary and Respiratory Medicine (298 citations) and Molecular Medicine (31 citations). Mark Bresnik has collaborated with scholars based in United States, United Kingdom and France. Frequent co-authors include Ramin Ebrahimi, Oliver A. Cornely, Johan Maertens, Raoul Herbrecht, Andrew J. Ullmann, Markus Ruhnke, Anne Thiébaut, Emilio Bouza, Angelika Boehme and M. Aoun. Their work appears in journals such as Journal of Cystic Fibrosis, Journal of Antimicrobial Chemotherapy, Mycoses, Clinical Microbiology and Infection and Antimicrobial Agents and Chemotherapy.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.